INTRODUCTION
============

The logic of regulatory-protein-mediated transcriptional regulation depends on whether the regulatory protein is an activator (positive control) or a repressor (negative control). However, optimization of gene expression often requires that certain promoters are up-regulated while others are turned down. The most compact design for this task is a repression-activation switch (transcriptional switch), where two promoters share a common regulatory region in such a way that one of the two promoters is subjected to positive regulation by the very same protein which represses the activity of the second promoter ([@B1]). λ CI is one of the best-known examples of a protein which can simultaneously repress and activate two adjacent promoters ([@B2]). Activators are generally more suitable for such differential regulation than repressors because they are typically dual-function regulators ([@B3]). Binding of a protein in the core promoter region can interfere with RNAP binding and therefore result in decreased levels of transcription, even if the protein functions as an activator in different contexts. Conversely, some repressors can activate transcription directly in certain contexts by inducing a specific DNA bend ([@B4]) or by contacting RNAP ([@B5]), or indirectly by repressing another repressor. The two divergent promoters involved in repression-activation switches typically show a certain degree of overlap ([@B1]). For example, the major promoter *P*~1~ of the *aroP* gene is repressed by the cofactor-TyrR-RNAP complex formed at the overlapping divergent *P~*3*~* promoter. Binding of the cofactor-TyrR complex itself is not sufficient for repression of *P*~1~, RNAP has to be recruited to the *P~*3*~* promoter ([@B6]). In principle binding of RNAP to one promoter of a repression-activation switch can inhibit RNAP binding to the overlapping other promoter ([@B6],[@B7]) or interfere with open complex formation at a nearby promoter ([@B8]). Therefore, RNAP itself can act as a transcriptional regulator. In this article we use a mathematical model to investigate interference of overlapping promoters. We explore the unique opportunities of transcriptional regulation provided by overlapping promoters, and provide an experimental example for using a repressor protein as an activator.

MATERIALS AND METHODS
=====================

Strain and plasmid construction
-------------------------------

Synthetic regulatory regions were created by PCR and inserted between the *Eco*RI and *Pst*I sites of plasmid pSEM2027 ([@B3]). Then the constructed regulatory regions, together with the upstream terminator region, were inserted upstream of the *uid*A ORF in the *Escherichia coli* MG1655 chromosome by recombineering as described before ([@B3]). Regulation of the *uid*A (*gus*A) reporter gene in the resulting cells was evaluated on a population level, by plating cells on two separate LB plates, both containing the chromogenic substrate of β-[d]{.smallcaps}-glucuronidase (X-gluc) and one of them also containing 1 mM IPTG. Sequences were verified and are shown in [Figure 4](#F4){ref-type="fig"}. Templates for *in vitro* transcription were created by inserting the regulatory regions between the *Eco*RI and *Pst*I sites of plasmid pSEM2008 ([@B9]). In this plasmid, transcription initiated at promoter *P* is terminated by an *rpoC* terminator, and transcription from *P*~REV~ is terminated by *rrnB* T2.

In vitro transcription
----------------------

Transcription reactions were performed as described previously ([@B10]). The reaction mixture (50 µl) contained 20 mM Tris--acetate pH 7.8, 10 mM magnesium acetate, 200 mM potassium glutamate and 2 nM supercoiled DNA template. LacI was used at 30 nM when present. Twenty nanomolar RNA polymerase was added before incubating the reactions at 37°C for 5 min. Transcription was started by the addition of 1.0 mM ATP, 0.1 mM GTP, 0.1 mM CTP, 0.01 mM UTP and 5 µCi of \[α-^32^P\]UTP (3000 Ci/mmol). Reactions were terminated after 10 min by addition of an equal volume of transcription loading buffer (0.025% bromophenol blue, 0.025% xylene cyanol, 0.01 M EDTA and 90% deionized formamide). After heating at 90°C for 3 min, the samples were loaded onto an 8% polyacrylamide--urea DNA sequencing gel. RNA bands were quantified using the ImageQuant™ PhosphorImager (Molecular Dynamics, CA, USA). The RNA1 transcript, which is not affected by LacI binding, was used as an internal control between lanes. Band intensities were background corrected. The uracil content of RNAs was also considered when two different transcripts were compared.

Mathematical modeling
---------------------

Let *θ*~1~ be occupation of *P*~1~ and *θ*~2~ the occupation of promoter *P*~2~. With denoting the on rate and the elongation initiation rate (firing rate) for *P*~1~, the total intrinsic activity of the *P*~1~ promoter is given by steady-state equation: giving where the promoter aspect ratio, . Equivalently the aspect ratio is where the superscript 0 refers to isolated promoters. This aspect ratio approaches ∞ when *θ*→1. The strength of the promoter *P*~1~ is corresponding to an average time between subsequent elongation initiations: a time which is the sum of two subsequent times.

In case of two overlapping promoters, *P*~1~ and *P*~2~, there are three possibilities: (i) *P*~1~ is occupied by RNAP (probability = *θ*~1~); (ii) *P*~2~ is occupied by RNAP (probability = *θ*~2~); and (iii) both promoters are free (probability = 1 − *θ*~1~ − *θ*~2~). The steady state equations for two overlapping promoters are: which also reads: with determinant det = (*α*~1~ + 1) × (*α*~2~ + 1) − *α*~1~ × *α*~2~ = *α*~1~ + *α*~2~ + 1 giving which each should be normalized by the expected occupancy when there is no conflicting promoter \[i.e. from [Equation (2)](#M2){ref-type="disp-formula"}\] to obtain promoter activities expressed as a fraction of intrinsic promoter activities: In terms of *θ*^0^ the equation expressing the relative *P*~1~ activity ([Figure 2](#F2){ref-type="fig"}) reads: In this model we do not consider the time that the elongating RNAP spends transcribing the region which constitutes the overlapping other promoter. The length of this region depends on the topology of the overlapping promoters. In the case when promoters are oriented tail to tail, this time is negligible, however when promoters are oriented head-to-head, the whole region constituting the overlapping other promoter has to be transcribed, which takes ∼1 s for the elongating RNAP (assuming elongation speed of 50 nt/s). This effect would increase the aggressiveness of strong promoters (which by definition initiate elongation frequently).

RESULTS AND DISCUSSION
======================

Analyzing the recently published transcription unit architecture database of the *E. coli* genome ([@B11]), we found that ∼314 of 2281 forward promoters overlap with a reverse promoter ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkr390/DC1)). RNAP occupies ∼75 bp (from −55 to +20) when sitting on the promoter ([@B12]), however, our list is more conservative, considering overlaps only in the regions from −40 to +10. Promoters can be arranged head-to-head or tail-to tail ([Figure 1](#F1){ref-type="fig"}). We found three fundamentally different arrangements: (i) each promoter transcribes a gene and one or more regulatory proteins are identified which affect transcription of at least one of the promoters directly (marked red in [Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkr390/DC1)); (ii) each promoter transcribes a gene but no regulatory proteins are known to bind the promoter region (marked green in [Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkr390/DC1)); and (iii) only one of the promoters transcribe an annotated gene (marked yellow in [Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkr390/DC1)). In the latter case the other promoter could transcribe a regulatory antisense RNA ([@B13]) or act as a regulatory RNAP binding site which interferes with the promoter transcribing the annotated gene. A significant proportion of promoters in *E. coli* are bound by RNAP but lack transcriptional activity ([@B14]), which also supports the hypothesis that RNAP plays an active role in regulation. Because overlapping promoters are common in the *E. coli* genome, we have built a mathematical model to investigate how the level of interference depends on the characteristics of the two promoters involved. A related phenomenon, interference of an elongating RNAP with a convergent but non-overlapping promoter, has been described and modeled recently ([@B15],[@B16]). Our model shows that the mutual interference of overlapping promoters is independent of the relative intrinsic strength of promoters, it only depends on the aspect ratios ([@B16]) \[tendency of promoter to be occupied by RNAP, see [Equation (3)](#M3){ref-type="disp-formula"} in 'Materials and Methods' section\]. Promoters which successfully inhibit the other overlapping promoter have a high aspect ratio ([Figure 2](#F2){ref-type="fig"}). Therefore, the capacity of a promoter to inhibit an overlapping promoter, termed the aggressiveness of the promoter, is determined by the fraction of time it is occupied by RNAP. For large aspect ratios (\>\>1), the mutual influence scales with the ratio of the two aspect ratios. Figure 1.Arrangements of overlapping promoters. Promoters can be arranged head-to-head (right) or tail-to tail (left). Transcription start points (tsp) are indicated by arrows. The *tsp* of the forward promoter (*P*~FWD~) serves as +1 in the numbering system. Gray boxes show the DNA regions occupied by RNAP (from −40 to +10). The −10 (blue) and −35 (yellow) promoter elements are indicated. All the reverse promoters (*P*~REV~) with a tsp falling into the red region (from −80 to +20) are considered to be overlapping promoters with *P*~FWD~. Figure 2.Computed prediction of interference of overlapping promoters. Activity of a promoter (*P*~1~) in terms of its own and the opposing promoter\'s (*P*~2~) aspect ratios (*α~1~* and *α~2~*) (left panel). Activity of promoter *P*~1~ in terms of its own and the opposing promoter\'s basal occupancies (*θ~1~^0^* and *θ~2~^0^*) (right panel). Activities are measured in fraction of the intrinsic promoter activity of *P*~1~. Simulations were done with two promoters arranged tail-to-tail, with 1 bp overlap.

Activities of overlapping promoters depend on (i) the intrinsic activity of the individual promoters, (ii) promoter interference and (iii) the effect of regulatory proteins. Therefore, the activity of overlapping promoters can be regulated in different ways. The simplest case is when no regulatory proteins are involved. In this case RNAP partitioning between the two promoters is determined by the concentration of the free RNAP holoenzyme and its affinity to the promoters. For example, the lower affinity promoter will inhibit the higher affinity promoter to a lesser extent as RNAP availability decreases. When a regulatory protein affects only one of the promoters directly, the indirect effect of regulation on the two promoters depends on whether the regulated promoter becomes more or less aggressive and not whether it becomes stronger (activated) or weaker (repressed). Therefore depending on the characteristics of the two promoters, the interference can enhance or suppress the effect of the regulator. The change in the aggressiveness of the regulated promoter depends on how the regulator changes the time RNAP spends at the promoter DNA. For example, activators can act by enhancing promoter binding and/or increasing the rates of the downstream steps of transcription initiation. Increasing the affinity of the promoter means that RNAP spends more time on DNA, however, faster transcription initiation results in less time spent on the DNA. Similarly, repressors can decrease the rate of promoter loading by inhibiting RNAP binding (steric hindrance) ([@B17]) or decrease the firing rate by trapping a promoter-bound RNAP (contact inhibition) ([@B5]). Steric hindrance can efficiently reduce the time RNAP spends on DNA, thus allowing the overlapping promoter to be transcribed. However, a trapped RNAP would sit on the promoter for a longer time and inhibit transcription of the overlapping promoter. We explored these scenarios by simulating how repression or activation changes transcription of overlapping promoters of different nature. Repression of strong promoters was simulated by 10-fold reduction of the RNAP binding rate (*k*~ON~) or by a 10-fold decrease in the firing rate (*k*~F~). Activation of weak promoters was simulated by a 10-fold increase in the RNAP binding rate (*k*~ON~) or in the firing rate (*k*~F~) ([Figure 3](#F3){ref-type="fig"}, [Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkr390/DC1)). In general, changing the RNAP binding rate has a differential effect on the activity of two promoters ([Figure 3](#F3){ref-type="fig"}, red bars), while both promoter activities are changed in the same direction when the firing rate is altered ([Figure 3](#F3){ref-type="fig"}, blue bars). Differential regulation obtained by the direct and indirect regulatory effects can result in a transcriptional switch. However, a successful transcriptional switch requires different activities of the overlapped promoters in the absence of the regulatory protein combined with a strong effect of differential regulation on both promoters. Promoter activities in the absence of the regulator are determined by the intrinsic promoter activities and by the aggressiveness of the promoters. Therefore high activity differences can be obtained by e.g. (i) overlapping a strong and aggressive promoter with a non-aggressive promoter ([Figure 3](#F3){ref-type="fig"}A), or (ii) overlapping a strong and a weak promoter which do not interfere with each other (both being non-aggressive) ([Figure 3](#F3){ref-type="fig"}B). In the first case repression directly decreases the activity and aggressiveness of the strong promoter, allowing transcription of the overlapping non-aggressive promoter ([Figure 3](#F3){ref-type="fig"}A). In the second case increasing the loading rate of the weak promoter increases its activity and makes the promoter more aggressive, thus repressing the overlapping strong and non-aggressive promoter ([Figure 3](#F3){ref-type="fig"}B). However, in this setup, repression of the strong promoter by decreasing the loading rate does not affect the activity of the overlapping weak promoter ([Figure 3](#F3){ref-type="fig"}B). This example shows that direct and indirect regulation can affect promoters to different extents, and allow practically independent regulation of one of the promoters. In certain cases the regulated promoter remains unchanged while the indirect effect on the overlapping promoter is significant. For instance, increasing the RNAP binding rate for a weak promoter, which is limited by the firing rate, has little effect on the promoter\'s activity. However, it increases the time RNAP spends at the promoter, therefore it can strongly repress an overlapping promoter ([Figure 3](#F3){ref-type="fig"}C). The possibility of independent regulation of overlapping promoters can contribute to the compact genome organization of prokaryotes. Figure 3.Examples of simulated responses of overlapping promoters to regulation of one of the promoters. Regulation of the promoters (arrows) is shown on the left. Bars show activities of promoters labeled with green arrows. Black bars show intrinsic promoter activities. Unregulated promoter strengths (firing frequencies in seconds) and aggressiveness of promoters (the fraction of time RNAP spends at the promoter, %) are shown on the top of each panel. White bars show promoter activities when the two promoters, *P*~1~ and *P*~2~ overlap. Red bars indicate differential effect of regulation while blue bars indicate that both promoter activities change in the same direction.

The third possibility is that a regulatory protein affects both promoters directly. In this case the indirect effect of altered promoter interference adds to the direct effect of the regulatory protein. Therefore, it provides a suitable mechanism to enhance the contrast of gene expression levels in transcriptional switches. Such a phenomenon has been observed at the *λ P*~R~/*P*~RM~ promoters, where the CI repressor inhibits *P*~R~ and activates *P*~RM~ directly ([@B2]). *P*~RM~ is also activated indirectly through removing the *P*~R~-bound polymerase which inhibits *P*~RM~ activity ([@B8]).

Our simulations suggest that overlapping promoters can provide unique opportunities of regulation, which can be exploited in the construction of synthetic genetic circuits. For example, a non-aggressive promoter is inhibited when overlapped with a strong and aggressive promoter. In this case the non-aggressive promoter can be activated (derepressed) by a repressor which inhibits RNAP binding to the strong promoter. The potential advantage of this setup is that practically any DNA binding protein can be used for repression of the aggressive promoter, and no direct effects are required for the activation of the non-aggressive promoter. To test the feasibility of such regulation we constructed the synthetic system depicted in [Figure 4](#F4){ref-type="fig"}. We overlapped a promoter (*P*) which has a weak −35 and a consensus −10 element with a reverse promoter (*P*~REV~) which has consensus −10 and −35 elements and also contains the extended −10 element. The transcription start site of *P*~REV~ overlaps with a symmetric LacI operator site (*O*). The position of the operator site was chosen to be neutral for transcription of *P* ([@B18]). As a first step, activity of *P* was assayed qualitatively *in vivo* using a *P* promoter-*uidA* (encoding β-glucuronidase) transcriptional fusion in the presence and absence of IPTG ([Figure 5](#F5){ref-type="fig"}). We observed a decrease in *P* activity in the presence of IPTG, suggesting that as opposed to the natural logic of the *lac* system (lanes 1 and 2), here *P* is inactivated in the presence of the inducer (lanes 5 and 6). To understand the system more quantitatively, we measured activities of both *P* and *P*~REV~ in the presence and absence of LacI *in vitro* ([Figures 5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"})*.* [Figure 5](#F5){ref-type="fig"} shows that *P*~REV~ inhibits *P* activity, and this inhibition depends on having an accessible transcription start site in *P*~REV~ because it is alleviated when LacI inhibits RNAP binding to *P*~REV~ by binding to the overlapping *lac* operator site (compare lanes 5 and 6). We observed ∼4-fold higher *P* activity in the presence of LacI ([Figure 6](#F6){ref-type="fig"}), demonstrating that LacI can indeed function as an activator of *P* through the repression of *P*~REV~. We found that a single base pair mutation in the consensus −10 element (*P*~REV\*~) or a two base-pair mutation in the −35 element (*P*~\*REV~) of *P*~REV~ results in loss of repression of *P* (compare lanes 3 and 4, and 7 and 8, respectively), confirming the model prediction that overlapping promoters do not necessarily interfere with each other. While this observation demonstrates that the genome size could be reduced by using overlapping promoters, analysis of natural overlapping promoters is needed to estimate the potential extent of genome compaction that can be achieved by this mechanism. In addition, these control experiments demonstrate that LacI binding does not control *P* directly, since the addition of LacI does not have a substantial effect on *P* when *P*~REV~ is mutated ([Figures 5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}B). Interestingly, these mutations affect the aggressiveness of *P*~REV~ but not its overall strength. The mutant promoters are easier to repress by LacI than the wild-type *P*~REV~ promoter ([Figure 6](#F6){ref-type="fig"}A), likely because the affinity of RNAP to the mutant DNA sequences is decreased. The decreased on rate itself would result in reduced promoter activity if the elongation initiation rate remains unchanged. However, we did not observe such a decrease in the activity of the mutant promoters ([Figure 6](#F6){ref-type="fig"}A), suggesting that mutations in the consensus promoter elements speed up elongation initiation. Our results are in agreement with the previous observation that strong RNA polymerase-promoter interactions stall the polymerase at the promoter, thereby reducing the rate of promoter escape ([@B19]). We suggest that the mutant promoters are less successful in inhibition of the *P* promoter because both the decreased on rate and the faster elongation initiation reduce the time RNAP spends on the promoter DNA. Unlike these mutations, LacI binding reduces only the promoter availability (on rate), resulting in lower promoter activity because of the unchanged elongation initiation rate. Our results show that when *P*~REV~ has only 65% of its activity, *P* becomes 1.65 times stronger, and when *P*~REV~ activity is reduced to 16% than promoter interference is practically eliminated, further repression of *P*~REV~ by LacI does not increase *P* activity substantially ([Figure 6](#F6){ref-type="fig"}). Figure 4.Synthetic regulatory region used in the *in vitro* and *in vivo* studies. Schematic drawings of regulatory regions are shown on the left. Gray boxes represent promoters, in which the −35 elements (yellow) and −10 elements (blue) are highlighted. Transcription start points are indicated by arrows. The red box represents a symmetric LacI operator site (*O*). The promoter elements are not shown when mutated in the reverse promoter *P*~REV~ (typed boldface and underlined in the sequence). Figure 5.Regulation of overlapping synthetic promoters *in vitro* and *in vivo*. Schematic drawings of regulatory regions are shown on top (see also [Figure 4](#F4){ref-type="fig"}). Results of *in vitro* transcription from the promoter *P* and *P*~REV~ in the presence and absence of LacI are shown below each drawing. The RNA1 transcript, which is not affected by LacI binding, was used as an internal control between lanes (see also [Supplementary Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gkr390/DC1)). The regulatory regions were inserted into the *E. coli* chromosome in such orientation that the promoter *P* transcribes the *uidA* reporter gene, encoding β-glucuronidase. Expression of the reporter gene in the presence and absence of IPTG is indicated by the blue color of colonies, resulted from degradation of X-gluc by the β-glucuronidase enzyme. Figure 6.The effect of LacI on promoter activities. *In vitro* transcription was performed at different LacI concentrations and the amount of *P* and *P*~REV~ transcripts were quantified as described in the 'Materials and Methods' section. (**A**) *P*~REV~ (black dots), *P*~REV\*~ (gray circles), *P*~\*REV~ (gray squares) activities as a function of LacI concentration. The background corrected and RNA1 normalized values were normalized for the corresponding promoter activities in the absence of LacI (=1). The relative activities of *P*~REV~, *P*~REV\*~ and *P*~\*REV~ in the absence of LacI are 1.00, 2.38 and 0.99, respectively. (**B**) *P* promoter activities as a function of LacI concentration when the *P* promoter is overlapped with *P*~REV~ (black dots), *P*~REV\*~ (gray circles) and *P*~\*REV~ (gray squares). The background corrected and RNA1 normalized values were normalized for the promoter activity of the *P* promoter when overlapped with *P*~REV~, in the absence of LacI (=1). For comparison of activities in panels (A) and (B), *P*~REV~ shows ∼80 times higher activity than *P* when LacI is absent.

In summary our results show that given the proper sequence context, RNAP binding to one promoter can repress an other overlapping promoter (*P*). Inhibition of RNAP binding to (*P*~REV~) by a DNA binding protein (LacI) occupying a site overlapping with the *P*~REV~ promoter can activate the transcription of (*P*), resulting in a compact and simple activation-repression switch.
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